Skip to main content
Clinical Trials/ACTRN12610000776000
ACTRN12610000776000
Recruiting
未知

The use of novel protein biomarkers in predicting clinical outcomes in patients with localised and metastatic colorectal cancer

Cancer Institute NSW0 sites200 target enrollmentSeptember 16, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Cancer Institute NSW
Enrollment
200
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 16, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cancer Institute NSW

Eligibility Criteria

Inclusion Criteria

  • Patients with biopsy proven metastatic or locally advanced colorectal cancer starting chemotherapy involving infusional 5\-fluoroouracil or
  • Patients with biopsy proven metastatic colorectal cancer for symotomatic management only
  • Eastern Cooperative Oncology Group (ECOG) performance status 0\-2 AND
  • age over 18 years AND
  • ability to comply and provide informed written consent

Exclusion Criteria

  • Pior chemotherapy for metastatic colorectal cancer or adjuvant chemotherapy in the last 6 months
  • Other active malignancy
  • Active autoimmune, inflammatory disease or infection
  • Symptoms and signs of cancer cachexia

Outcomes

Primary Outcomes

Not specified

Similar Trials